Abstract
Fruits and vegetables have protective effects against many human cancers, including pancreatic cancer. Isoprenoids are one class of phytochemicals which have antitumor activity, but little is known about their effects on cancer of the pancreas. We tested the hypothesis that isoprenoids would inhibit the growth of pancreatic tumor cells. Significant (60–90%) inhibition of the anchorage-independent growth of human MIA PaCa2 pancreatic tumor cells was attained with 25 μM farnesol, 25 μM geranylgeraniol, 100 μM perillyl amine, 100 μM geraniol, or 300 μM perillyl alcohol. We then tested the relative in vivo antitumor activities of dietary farnesol, geraniol, and perilyl alcohol against transplanted PC-1 hamster pancreatic adenocarcinomas. Syrian Golden hamsters fed geraniol or farnesol at 20 g/kg diet exhibited complete inhibition of PC-1 pancreatic tumor growth. Both farnesol and geraniol were more potent than perillyl alcohol, which inhibited tumor growth by 50% at 40 g/kg diet. Neither body weights nor plasma cholesterol levels of animals consuming isoprenoid diets were significantly different from those of pair-fed controls. Thus, farnesol, geraniol, and perillyl alcohol suppress pancreatic tumor growth without significantly affecting blood cholesterol levels. These dietary isoprenoids warrant further investigation for pancreatic cancer prevention and treatment.
Similar content being viewed by others
Abbreviations
- NMR:
-
nuclear magnetic resonance
References
Steinmetz, K.A., and Potter, J.D. (1991) Vegetables, Fruit, and Cancer. I. Epidemiology, Cancer Causes and Control 2, 325–357.
Block, G., Patterson, B., and Subar, A. (1992) Fruit, Vegetables, and Cancer Prevention: A Review of the Epidemiological Evidence, Nutr. Cancer 18 1–29.
Ji, B.T., Chow, W.H., Gridley, G., McLaughlin, J.K., Dai, Q., Wacholder, S., Hatch, M.C., Gao, Y.T., and Fraumeni, J.F. (1995) Dietary Factors and the Risk of Pancreatic Cancer: A Case-Control Study in Shanghai, China, Cancer Epidemiology, Biomarkers & Prevention 4, 885–893.
McGarvey, D.J., and Croteau, R. (1995) Terpenoid Metabolism, Plant Cell 7, 1015–1026.
Bansal, V.S., and Vaidya, S. (1994) Characterization of Two Distinct Allyl Pyrophosphatase Activities from Rat Liver Microsomes, Arch. Biochem. Biophys. 315, 393–399.
Case, G.L., He, L., Mo, H., and Elson, C.E. (1995) Induction of Geranyl Pyrophosphate Pyrophosphatase Activity by Cholesterol-Suppressive Isoprenoids, Lipids 30, 357–359.
Goldstein, J.L., and Brown, M.S. (1990) Regulation of the Mevalonate Pathway, Nature 343, 425–430.
Elson, C.E., and Yu, S.G. (1994) The Chemoprevention of Cancer by Mevalonate-Derived Constituents of Fruits and Vegetables, J. Nutr. 124, 607–614.
Elegbede, J.A., Elson, C.E., Qureshi, A., Tanner, M.A., and Gould, M.N. (1984) Inhibition of DMBA-Induced Mammary Cancer by the Monoterpene d-Limonene, Carcinogenesis 5, 661–665.
Elson, C.E., Maltzman, T.H., Boston, J.L., Tanner, M.A., and Gould, M.N. (1988) Anticarcinogenic Activity of d-Limonene During the Initiation and Promotion-Progression Stages of DMBA-Induced Rat Mammary Carcinogenesis, Carcinogenesis 9, 331–332.
Maltzman, T.H., Hurt, L.M., Elson, C.E., Tanner, M.A., and Gould, M.N. (1989) The Prevention of Nitrosomethylurea-Induced Mammary Tumors by d-Limonene and Orange Oil, Carcinogenesis 10, 781–785.
Wattenberg, L.W., and Coccia, J.B. (1991) Inhibition of 4-(methylnitrosoamino)-1-butanone Carcinogenesis in Mice by d-Limonene and Orange Oil, Carcinogenesis 12, 115–117.
Haag, J.D., Lindstrom, M.J., and Gould, M.N. (1992) Limonene-Induced Regression of Mammary Carcinomas, Cancer Res. 52, 4021–4026.
Crowell, P.L., and Gould, M.N. (1994) Chemoprevention and Therapy of Cancer by d-Limonene, CRC Crit. Rev. Oncogenesis 5, 1–22.
Mills, J.J., Chari, R.S., Boyer, I.J., Gould, M.N., and Jirtle, R.L. (1995) Induction of Apoptosis in Liver Tumors by the Monoterpene Perillyl Alcohol, Cancer Res. 55, 979–983.
Haag, J.D., and Gould, M.N. (1994) Mammary Carcinoma Regression Induced by Perillyl Alcohol, A Hydroxylated Analog of Limonene, Cancer Chemother. Pharmacol. 34, 477–483.
Stark, M.J., Burke, Y.D., McKinzie, J.H., Ayoubi, A.S., and Crowell, P.L. (1995) Chemotherapy of Pancreatic Cancer with the Monoterpene Perillyl Alcohol, Cancer Lett. 96, 15–21.
Shoff, S.M., Grummer, M., Yatvin, M.B., and Elson, C.E. (1991) Concentration-Dependent Increase of Murine P388 and B16 Population Doubling Time by the Acyclic Monoterpene Geraniol, Cancer Res. 51, 37–42.
Yu, S.G., Hildebrandt, L.A., and Elson, C.E. (1995) Geraniol, An Inhibitor of Mevalonate Biosynthesis, Suppresses the Growth of Hepatomas and Melanomas Transplanted to Rats and Mice, J. Nutr. 125, 2763–2767.
Adany, I., Yazlovitskaya, E.M., Haug, J.S., Voziyan, P.A., and Melnykovych, G. (1994) Differences in Sensitivity to Farnesol Toxicity Between Neoplastically- and Nonneoplastically-Derived Cells in Culture, Cancer Lett. 79, 175–179.
Haug, J.S., Goldner, C.M., Yazlovitskaya, E.M., Voziyan, P.A., and Melnykovych, G. (1994) Directed Cell Killing (Apoptosis) in Human Lymphoblastoid Cells Incubated in the Presence of Farnesol: Effect of Phosphatidylcholine, Biochim. Biophys. Acta 1223, 133–140.
Voziyan, P.A., Haug, J.S., and Melnykovych, G. (1995) Mechanism of Farnesol Cytotoxicity: Further Evidence for the Role of PKC-Dependent Signal Transduction in Farnesol-Induced Apoptotic Cell Death, Biochem. Biophys. Res. Comm. 212, 479–486.
American Cancer Society (1996) Cancer Facts and Figures-1996, American Cancer Society, New York, New York, USA.
Egami, H., Takiyama, Y., Cano, M., Houser, W.H., and Pour, P.M. (1989) Establishment of Hamster Pancreatic Ductal Carcinoma Cell Line (PC-1) Producing Blood Group-Related Antigens, Carcinogenesis 10, 861–869.
Egami, H., Tomioka, T., Terpero, M., Kay, D., and Pour, D.M. (1991) Development of an Intrapancreatic Transplantable Model of Pancreatic Duct Adenocarcinoma in Syrian Golden Hamsters, Am. J. Pathol. 138, 557–561.
Phillips, L.R., Malspeis, L., and Supko, J.G. (1995) Pharmacokinetics of Active Drug Metabolites After Oral Administration of Perillyl Alcohol, An Investigational Antineoplastic Agent, to the Dog, Drug Metab. Dispos, 23, 676–680.
Fliesler, S.J., and Keller, R.K. (1995) Metabolism of [3H]-Farnesol to Cholesterol and Cholesterogenic Intermediates in the Living Rat Eye, Biochem. Biophys. Res. Comm. 210, 695–702.
Chadha, A., and Madyastha, K.M. (1984) Metabolism of Geraniol and Linalool in the Rat and Effects on Liver and Lung Microsomal Enzymes, Xenobiotica 14, 365–374.
Clegg, R.J., Middleton, B., Bell, D., and White, D.A. (1980) Inhibition of Hepatic Cholesterol Synthesis and (S)-3-Hydroxy-3-Methylglutaryl-CoA Reductase by Mono and Bicyclic Monoterpenes Administered in vivo, Biochem. Pharmacol. 29, 2125–2127.
Clegg, R.J., Middleton, B., Bell, D., and White, D.A. (1982) The Mechanism of Cyclic Monoterpene Inhibition of Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in vivo in the Rat, J. Biol. Chem. 257, 2294–2299.
Qureshi, A.A., Mangels, W.R., Din, Z.A., and Elson, C.E. (1988) Inhibition of Hepatic Mevalonate Biosynthesis by the Monoterpene, d-Limonene, J. Agric. Food Chem. 36, 1220–1224.
Ren, Z., and Gould, M.N. (1994) Inhibition of Ubiquinone and Cholesterol Synthesis by the Monoterpene Perillyl Alcohol, Cancer Lett. 76, 185–190.
Correll, C.C., Ng, L., and Edwards, P.A. (1994) Identification of Farnesol as the Nonsterol Derivative of Mevalonic Acid Required for the Accelerated Degradation of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase, J. Biol. Chem. 269, 17390–17393.
Meigs, T.E., Roseman, D.A., and Simone, R.D. (1996) Regulation of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Degradation by the Nonsterol Mevalonate Metabolite Farnesol in vivo, J. Biol. Chem. 271, 7916–7922.
Forman, B.M., Goode, E., Chen, J., Oro, A.E., Bradley, D.J., Perlmann, T., Noonan, D.J., Burka, L.T., McMorris, T., Lamph, W.W., Evans, R.M., and Weinberger, C. (1995), Identification of a Nuclear Receptor That Is Activated by Farnesol Metabolites, Cell 81, 687–693.
Author information
Authors and Affiliations
About this article
Cite this article
Burke, Y.D., Stark, M.J., Roach, S.L. et al. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 32, 151–156 (1997). https://doi.org/10.1007/s11745-997-0019-y
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-997-0019-y